• Prostate Cancer Treatment

    Zytiga (Arbiraterone), Xtandi (MDV3100), Jevtana (Cabazitaxel), Provenge (Sipuleucel-T), Taxotere (Docetaxel)

  • Lung Cancer Treatment

    Xalkori (Crizotinib), Alimta (Pemetrexed Disodium), Iressa (Gefitinib), Taxol (Paclitaxel), Tarceva (Erlotinib Hydrochloride)

  • Kidney Cancer Treatment

    Sutent (Sunitinib), Nexavar (Surafenib), Votrient (Pazopanib), Afinitor (Everolimus), Inlyta (Axitinib)

  • Colon Cancer Treatment

    Stivarga (Regorafenib), Avastin (Bevacizumab), Erbitux (Cetuximab), Vectibix (Panitumumab), Wellcovorin (Leucovorin Calcium), Zaltrap (Ziv-Aflibercept)

  • Breast cancer Treatment

    Perjeta (pertuzumab), Afinitor (Everolimus), Herceptin (Trastuzumab), Tykerb (Lapatinib Ditosylate), Xeloda (Capecitabine)

Newsletter
Contact Cancer Treatment Meds
  • Call toll free from the US USA (Toll Free) :1-800-805-7239 Call toll free from the US PRC: 10-800-713-1275(N), 10-800-130-1235(S)
  • Call toll free from the US Aussie: +61-03-9013-3771 Call toll free from the US Бесплатный номер для звонков из России :8-800-100-6943
Contact Us Online now
View as
Sort by
Display per page

Buy Afinitor

Buy brand name Afinitor 10 mg 30 Tablets.
Call for pricing

Afinitor Alternatives - Nexavar/ Votrient / Inlyta / Torisal

Everolimus is an effective drug used for the treatment of certain types of cancer such as Breast cancer, PNT and Renal cell carcinoma. However, it may not possibly be as effective in some patient as it is in others. It has been seen to have led to adverse reactions in some patients, due to which its use had to be terminated. Hence in such cases, Afinitor Alternatives may be administered to the patients in order to avoid adverse effects. Following are the different drugs that prove to be very effective Afinitor Alternatives:

Afinitor VS Nexavar

As far as the treatment of RCC is considered, Nexavar marketed under the coalition of Bayer and Onyx, is one of the potent rivals of Everolimus. Although the mechanism of action is principally different; yet both work to bring the tumour growth to a halt and hence improve or, at least maintain the patient’s health.

Afinitor VS Votrient

Votrient is another Afinitor alternative marketed by the pharmaceutical company, GlaxoSmithKline. The drug works as a tyrosine kinase inhibitor and exhibits a strong antitumor activity in addition to its anti-angiogenetic action.

Afinitor VS Inlyta

After sutent – the first line treatment of RCC – Pfizer has launched another drug for RCC under the trade name of Inlyta. The drug has been demonstrated to be more effective than Bayer’s Nexavar through trials.

Afinitor VS Torisel

Torisel is yet another alternative of Everolimus marketed by Wyeth pharmaceuticals.

Afinitor and Sutent

Sutent, manufactured by Pfizer, is a drug indicated for RCC, GIST and PNT. It works as a tyrosine kinase inhibitor and thus exhibits strong anti-tumour activity. Afinitor and Sutent both are very effective drugs for specific types of cancer and one may outshine the other in one aspect or the other. However, in case of pancreatic neuro-endocrinal tumours both the drugs metaphorically stand against each other. Establishing a comparison between Afinitor and Sutent is to some extent difficult, since there are practically, very minute parameters to bring in to consideration in order to compare Afinitor and Sutent. However, a survey demonstrates that the patients on Everolimus showed more occurrences of seizures as compared to those on sutent. In addition, a phase III study, consisting of two trials (one on the efficacy of sutent and other on that of everolimus) also showed the mean progression free survival (PFS) of PNT patients on sutent to be 11.4 months while the PFS of patients on Everolimus turned out to be 11 months. Although, the two figures are very close, yet for a patient fighting against fatality; even a small division of time may matter a great deal.